The global seasonal affective disorder therapeutics market is estimated to witness potential growth during the forecast period. The major factors contributing to the growth of the market include the rising awareness regarding mental health and rising prevalence of seasonal affective disorder and depression. Rising insurance claims for mental health has shown emerging awareness regarding mental health. As per the Association of British Insurers (ABI), in 2017, mental health was the most common cause of claim on income protection policies in the UK. As a result, the ABI engage with the health and protection industry and charities to promote remarkable access to insurance for individuals suffering from mental health conditions.
Request a free sample of our report on Global Seasonal Affective Disorder Therapeutics Market: https://www.omrglobal.com/request-sample/seasonal-affective-disorder-therapeutics-market

Emerging nations have also been started emphasizing on mental health owing to the increasing suicide rates. For instance, in India, the Insurance Regulatory and Development Authority of India (IRDAI) has directed the insurers to offer medical insurance to cover mental illness treatments. According to Sec 21(4) of the Mental Healthcare Act, 2017, every medical insurer will offer coverage to treat mental illness the same as available for the treatment of physical illness. In May 2018, this mental healthcare act 2017 came into appearance. These kinds of initiatives are supporting to increase awareness among people regarding mental health, which in turn, increases the demand for seasonal affective disorder treatment.
A full report of Global Seasonal Affective Disorder Therapeutics Market Is available at https://www.omrglobal.com/industry-reports/seasonal-affective-disorder-therapeutics-market

Global Seasonal Affective Disorder Therapeutics Market Segmentation
By Disorder Type
Unipolar Disorder
Bipolar Disorder
By Treatment Type
Medications
Selective Serotonin Reuptake Inhibitors (SSRIs)
Monoamine Oxidase Inhibitors (MAOIs)
Norepinephrine-Dopamine Reuptake Inhibitors (NDRIs)
Others
Light Therapy
Others
Regional Analysis
North America
United States
Canada
Europe
UK
Germany
Italy
Spain
France
Rest of Europe
Asia-Pacific
China
India
Japan
Rest of Asia-Pacific
Rest of the World
Company Profiles
AbbVie Inc.
Active Wearables GmbH
Aura Day Light
Bristol-Myers Squibb Co.
Carex Health Brands
Eli Lilly & Co.
F. Hoffmann-La Roche AG
GlaxoSmithKline plc
H. Lundbeck A/S
Koninklijke Philips N.V.
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/seasonal-affective-disorder-therapeutics-market

About Us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research-based services.
For More Information, Visit https://www.omrglobal.com/
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404